Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

OBJECTIVE: The Austrian Azacitidine Registry is a multi-center database (ClinicalTrials.gov: NCT01595295). The nature and intent of the registry was to gain a comprehensive view of the use, safety and efficacy of the drug in a broad range of AML-patients treated in real-life scenarios. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Pleyer, Lisa, Stauder, Reinhard, Burgstaller, Sonja, Schreder, Martin, Tinchon, Christoph, Pfeilstocker, Michael, Steinkirchner, Susanne, Melchardt, Thomas, Mitrovic, Martina, Girschikofsky, Michael, Lang, Alois, Krippl, Peter, Sliwa, Thamer, Egle, Alexander, Linkesch, Werner, Voskova, Daniela, Angermann, Hubert, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655844/
https://www.ncbi.nlm.nih.gov/pubmed/23627920
http://dx.doi.org/10.1186/1756-8722-6-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655844/
https://www.ncbi.nlm.nih.gov/pubmed/23627920
http://dx.doi.org/10.1186/1756-8722-6-32

Ejemplares similares